UBS analyst Michael Ward lowered the firm’s price target on Lincoln National (LNC) to $37 from $43 and keeps a Neutral rating on the shares. The firm adjusted targets in the North American life insurance group as part of a Q1 earnings preview. UBS expects continued focus on disability margins with “relatively limited wiggle-room” given cyclicality and economic uncertainty. The firm rolled its target to 2027 from 2026 estimates.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNC:
- Lincoln National price target lowered to $42 from $44 at Barclays
- Lincoln National Enters New $2 Billion Credit Agreement
- Lincoln National re-initiated with an Outperform at Keefe Bruyette
- Lincoln National appoints Lacey as SVP, Head of Institutional Sales
- Lincoln National price target lowered to $44 from $45 at Barclays